Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can remote rehab help lung patients breathe easier?

NCT ID NCT06636487

Symptom relief Sponsor: Copenhagen University Hospital, Hvidovre Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether home-based or video-supervised exercise programs are acceptable and helpful for people with chronic lung diseases like IPF, sarcoidosis, bronchiectasis, asthma, and other interstitial lung diseases. Fifty participants will be randomly assigned to one of three groups: supervised group tele-rehabilitation, a self-guided home program with weekly coaching, or usual care. The main goals are to see if patients are willing to join, stick with the program, and show signs of improved symptoms and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
pulmonary tele-rehabilitation and home-based pulmonary rehabilitation
What this could lead to
If successful, this could show that remote rehab programs are a practical option for people with chronic lung diseases, improving breathing and daily function.
What could go wrong
This is a small pilot study (50 people) testing feasibility, not effectiveness. Results may not apply to all patients, and adherence could be low.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Nov 2024

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

40 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Residency in the Capital Region of Copenhagen * A clinically assessed need for pulmonary rehabilitation including respiratory symptoms, corresponding to MRC grade 2 or higher and where: 1. Center-based PR is not standard available or 2. Center-based PR being declined by the patient * Able to stand up from a chair (height 44-46cm) and walk 10 meters independently (with or without a walking aid) * Capable of lifting both arms to horizontal with at least 1 kg dumbbells in each hand * And a minimum of one of the below mentioned diagnoses: 1. ILD (Interstitial lung disease, Idiopathic pulmonary fibrosis, Sarcoidosis): DLCO lower than 80 % or FVC lower than 80%, HRCT verified, Age higher than 40 years, Confirmed respiratory physician diagnosis 2. Asthma: With chronic airway obstruction, ACQ score higher than 1, FEV1 lower than 80%, Age higher than 50 years, Confirmed respiratory physician diagnosis of Asthma 3. Bronchiectasis: FEV1 lower than 80%, HRCT verified, Age higher than 40 years, Confirmed respiratory physician diagnosis Exclusion Criteria: * Cognitive impairment - unable to follow instructions * Impaired hearing or vision - unable to see or hear instruction from a tablet * Unable to understand and speak Danish * Comorbidities where the exercise content is contraindicated

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma bronchiale are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

asthma bronchiectasis idiopathic pulmonary fibrosis interstitial lung disease sarcoidosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma bronchiale Bronchiectasis Idiopathic pulmonary fibrosis (IPF) Interstitial lung diseases (ILD) Sarcoidosis

Contacts and locations

Locations

  • Copenhagen University Center, Amager

    Copenhagen, Greater Copenhagen, 2300, Denmark

  • Copenhagen University Center, Frederiksberg-Bispebjerg

    Copenhagen, Greater Copenhagen, 2400, Denmark

  • Copenhagen University Center, Herlev-Gentofte

    Gentofte Municipality, Greater Copenhagen, 2820, Denmark

  • Copenhagen University Center, Hillerød

    Hillerød, Greater Copenhagen, 3400, Denmark

  • Copenhagen University Center, Hvidovre

    Copenhagen, Greater Copenhagen, 2650, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.